We randomly assigned 96 patients to one of the four study groups : 40 participants ( 42 % ) received low-dose vaccine and eight participants ( 8 % ) received placebo in the low-dose groups ; 39 participants ( 41 % ) received high-dose vaccine , with nine ( 9 % ) participants assigned to receive placebo .